Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2020 | 1 |
2021 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Roles of long non-coding RNAs in the hallmarks of glioma.
Oncol Lett. 2020 Oct;20(4):83. doi: 10.3892/ol.2020.11944. Epub 2020 Aug 4.
Oncol Lett. 2020.
PMID: 32863916
Free PMC article.
Review.
Cell fusion in cancer hallmarks: Current research status and future indications.
Wang HF, Xiang W, Xue BZ, Wang YH, Yi DY, Jiang XB, Zhao HY, Fu P.
Wang HF, et al. Among authors: xue bz.
Oncol Lett. 2021 Jul;22(1):530. doi: 10.3892/ol.2021.12791. Epub 2021 May 16.
Oncol Lett. 2021.
PMID: 34055095
Free PMC article.
Review.
Item in Clipboard
Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q, Xiang W, Yi DY, Xue BZ, Wen WW, Abdelmaksoud A, Xiong NX, Jiang XB, Zhao HY, Fu P.
Zhang Q, et al. Among authors: xue bz.
Stem Cell Res Ther. 2018 Aug 24;9(1):228. doi: 10.1186/s13287-018-0977-z.
Stem Cell Res Ther. 2018.
PMID: 30143053
Free PMC article.
Review.
Item in Clipboard
CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Xue BZ, Xiang W, Zhang Q, Wang HF, Zhou YJ, Tian H, Abdelmaksou A, Xue J, Sun MX, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P.
Xue BZ, et al.
Stem Cell Res Ther. 2021 Jul 13;12(1):394. doi: 10.1186/s13287-021-02458-8.
Stem Cell Res Ther. 2021.
PMID: 34256854
Free PMC article.
Item in Clipboard
Growth factors contribute to the mediation of angiogenic capacity of glioma-associated mesenchymal stem cells.
Zhang Q, Xiang W, Xue BZ, Yi DY, Zhao HY, Fu P.
Zhang Q, et al. Among authors: xue bz.
Oncol Lett. 2021 Mar;21(3):215. doi: 10.3892/ol.2021.12476. Epub 2021 Jan 19.
Oncol Lett. 2021.
PMID: 33552293
Free PMC article.
Item in Clipboard
CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression.
Zhang Q, Yi DY, Xue BZ, Wen WW, Lu YP, Abdelmaksou A, Sun MX, Yuan DT, Zhao HY, Xiong NX, Xiang W, Fu P.
Zhang Q, et al. Among authors: xue bz.
Cell Death Dis. 2018 Oct 27;9(11):1101. doi: 10.1038/s41419-018-1140-6.
Cell Death Dis. 2018.
PMID: 30368520
Free PMC article.
Item in Clipboard
Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Xue BZ, Xiang W, Zhang Q, Wang HF, Zhou YJ, Tian H, Abdelmaksou A, Xue J, Sun MX, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P.
Xue BZ, et al.
Stem Cell Res Ther. 2021 Sep 6;12(1):493. doi: 10.1186/s13287-021-02566-5.
Stem Cell Res Ther. 2021.
PMID: 34488861
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite